Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Y. Chai currently holds 5,550 shares of MAP Pharmaceuticals, Inc. (MAPP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Y. Chai has been a net seller of MAPP stock. They have purchased $0 and sold $3.3M worth of shares.
Christopher Y. Chai's most recent insider trade was on May 13, 2026, when they sold 5,550 shares at $0.00 per share.
Christopher Y. Chai serves as Executive at MAP Pharmaceuticals, Inc. (MAPP). They have executed 52 insider transactions totaling $3.3M over their tenure at the company.
Christopher Y. Chai holds the position of Executive at MAP Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Christopher Y. Chai has shown a selling trading pattern, with $0 in total purchases and $3.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher Y. Chai was on Aug 18, 2020, when they sold $745.3K worth of PRNB shares. This transaction involved 7,500 shares at $99.37 per share.
Christopher Y. Chai currently owns 5,550 shares of MAP Pharmaceuticals, Inc. (MAPP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Y. Chai's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Y. Chai has 52 Form 4 filings on record as an insider at MAP Pharmaceuticals, Inc..
Set alerts for Christopher Y. Chai and 40,000+ other insiders.